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Abstract Aneurysmal subarachnoid haemorrhage (aSAH)
is a devastating event with substantial case-fatality. Our
purpose was to examine which clinical and neuro-imaging
characteristics, available on admission, predict 60 day
case-fatality in aSAH and to evaluate performance of our
prediction model. We performed a secondary analysis of
patients enrolled in the International Subarachnoid Aneu-
rysm Trial (ISAT), a randomised multicentre trial to
compare coiling with clipping in aSAH patients.
Multivariable logistic regression analysis was used to
develop a prognostic model to estimate the risk of dying
within 60 days from aSAH based on clinical and neuro-
imaging characteristics. The model was internally vali-
dated with bootstrapping techniques. The study population
comprised of 2,128 patients who had been randomised to
either endovascular coiling or neurosurgical clipping. In
this population 153 patients (7.2%) died within 60 days.
World Federation of Neurosurgical Societies (WFNS)
grade was the most important predictor of case-fatality,
followed by age, lumen size of the aneurysm and Fisher
grade. The model discriminated reasonably between those
who died within 60 days and those who survived (c sta-
tistic = 0.73), with minor optimism according to bootstrap
re-sampling (optimism corrected c statistic = 0.70). Sev-
eral strong predictors are available to predict 60 day case-
fatality in aSAH patients who survived the early stage up
till a treatment decision; after external validation these
predictors could eventually be used in clinical decision
making.
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Introduction
Subarachnoid haemorrhage (SAH) is a devastating event,
which is marked by sudden onset of severe headache,
causing substantial case-fatality. In 85% of the patients, the
SAH is caused by rupture of an aneurysm (aSAH) [1, 2].
From those who survive the first month, approximately
one-third remains dependent with respect to daily activities
during their remaining lifetime [1]. Amongst patients who
regain independency, quality of life remains reduced [3].
Early prediction of short term outcome in terms of case-
fatality may support clinical decision making and may
provide realistic and evidence based expectations to
patients and relatives. Predictions may also be used to
classify patients according to prognostic risk, which may
be useful to compare outcome between different patient
series, to study treatment results over time, or to stratify
patients for randomised clinical trials (RCT).
Several other prognostic studies on outcome after aSAH
have been performed, but most included relatively small
numbers. Two included substantial numbers allowing
analysis of the effects of multiple independent factors [4,
5]. However, these studies did not examine case-fatality,
but arbitrarily dichotomized ordinal outcome scales
(modified Rankin Scale or Glasgow Outcome Scale).
Moreover, due to their design, these studies were unable to
examine the effect of treatment on prediction of outcome.
Our aim was to develop a prognostic model for 60 day
case-fatality, based on clinical features and neuro-imaging,
regularly readily available on admission to a neurological
or neurosurgical unit. These data were obtained from a
large RCT conducted in mainly European countries.
Methods
Patients
Data were collected prospectively by the Medical Research
Council funded International Subarachnoid Aneurysm
Trial (ISAT) (International Standard Randomised Con-
trolled Trial, number ISRCTN49866681). Full details of
the ISAT study are available elsewhere [6]. The aim of the
trial was to determine whether treatment using endovas-
cular coiling reduced the risk of patients being dependent
or dead at 1 year by 25 percent when compared with
neurosurgical treatment (clipping).
Predictors and outcome
We considered all patient characteristics that can be col-
lected easily and reliably within the first hours after hos-
pital admission and that were also present in the ISAT
database. These included age, gender, previous occurrence
of SAH, CT scan Fisher grading, lumbar puncture, World
Federation of Neurosurgical Societies (WFNS) grading,
number of intracranial aneurysms, location of the aneu-
rysm, maximum lumen size of the aneurysm, vasospasm on
angiography, and intended treatment by randomization.
Fisher grading of blood visible on a plain CT scan runs
from grade 1 (‘‘no blood visible’’) up to grade 4 (‘‘intra-
ventricular or intraparenchymal blood’’). Lumbar puncture
was not performed in all participants. If it was performed it
was graded 1 (‘‘no blood in cerebrospinal fluid’’) or 2
(‘‘xanthochromia or blood’’); 0 otherwise (‘‘no lumbar
puncture’’). WFNS scale runs from grade 1 (‘‘Glasgow
Coma Scale (GCS) 15 and no motor deficit’’) to grade 5
(‘‘GCS 3-6 with or without motor deficit’’). One category
additional to the standard WFNS scale was created in ISAT
for those in whom WFNS could not be assessed; ‘grade 6’.
The number of aneurysms was categorized in 1, 2, and 3 or
more intracranial aneurysms. We discerned four aneurysm
locations: Anterior Cerebral Artery (ACA), Internal Car-
otid Artery (ICA), Middle Cerebral Artery (MCA), and
Posterior Circulation (PC). The maximum lumen size of
the aneurysm was expressed in millimetres. Vasospasm
was examined on angiography and categorized as ‘none’,
‘mild’, ‘moderate’, or ‘severe’. Treatment was either neu-
rosurgical clipping or endovascular coiling; we used
treatment as allocated by the randomization procedure. We
developed the model based on cases with a complete set of
data. The outcome was 60 day case-fatality.
Model
We used univariate logistic regression analysis to estimate
the association between single predictors and outcome,
expressed as an odds ratio (OR). Predictors have a statis-
tically significant effect if the 95 percent confidence
interval (95% CI) does not include the value one. The
prediction model was developed with multivariable logistic
regression with backward stepwise selection. All potential
predictors were entered into the model and those that met
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Akaike’s Information Criterion (AIC) were selected into
the model. AIC compares models based on how well they
fit the data, but penalizes for the complexity of the model.
AIC requires that the increase in model v2 when entering a
new predictor has to be larger than two times the degrees of
freedom: v2 [ 2 df. When considering a predictor with one
df, such as gender, this implies that v2 has to exceed two,
equivalent to P \ 0.157. When considering a predictor
with two df, v2 [ 4, or P \ 0.135; and in case of four df,
v2 [ 8, or P \ 0.092 [7].
Performance
The performance of the model was assessed with respect to
calibration and discrimination. Calibration is the ability of
the model to produce unbiased estimates of the probability
of the outcome. Calibration was examined with a goodness
of fit test, which assesses agreement between predicted
and observed risks over the full range of predicted proba-
bilities [8].
Discrimination is the model’s ability to separate patients
with different outcomes. To quantify the discrimination,
we used the concordance (c) statistic. For binary outcomes,
c is identical to the area under the receiver operating
characteristic curve [7]. The c statistic evaluates whether
those with higher predicted risk are more likely to die
within 60 days among all possible pairs of patients with
different outcomes. A model with a c statistic of 0.5 has no
discriminative power at all, for example a coin flip. A
c statistic of 1.0 reflects perfect discrimination.
Model validation
The performance of a prediction model is generally worse
in new patients than initially expected. This ‘optimism’ can
be studied with internal validation techniques [7]. Internal
validity of our model was assessed with standard boot-
strapping procedures [7]. Bootstrapping involves drawing
samples of patients with replacement from the study pop-
ulation. Each sample can be considered as if one is
repeating the data collection with the same number of
patients and under identical circumstances as the original.
The multivariable logistic regression coefficients were re-
estimated in 300 bootstrap samples. Each of these 300
models was evaluated on the original sample. The average
difference in the c statistic was determined to indicate the
optimism in the initially estimated discriminative ability
[7]. A shrinkage factor was estimated from the bootstrap
validation procedure and we shrunk the regression coeffi-
cients to provide better predictions for future patients [7].
All statistical analyses were performed using R soft-
ware, version 2.8.1 (R foundation for statistical computing,
Vienna, Austria).
Results
A total of 2,143 patients were recruited into the ISAT trial
by 43 neurosurgical centres, mainly in Europe. CT scans of
14 patients were not performed or available, and in one
patient no information on vasospasm was available. We
excluded these cases from our analysis. Data on the out-
come were available for all patients. Thus, we performed
complete case analysis on 2,128 patients (99.3%) of whom
153 (7.2%) died within 60 days.
The distribution of patient characteristics of the study
population is presented in Table 1. For reasons of small
numbers in the ‘severe’ category of vasospasm, we
aggregated data from the ‘moderate’ and ‘severe’ catego-
ries into one category. Univariate analysis showed a sta-
tistically significant relation with 60 day case-fatality for
age, lumen size, Fisher grade, lumbar puncture, WFNS
grade, and vasospasm. Sex, location and number of aneu-
rysms and intended treatment were not significantly asso-
ciated with 60 day case-fatality (Table 1). In the
multivariable model with stepwise backward selection age,
lumen size, Fisher grade, and WFNS grade met AIC and
were included in the final model. In Table 2 the chi square
statistics with corresponding P-values are presented as well
as the point estimate of the OR. Age and WFNS grade were
the most important predictors.
The goodness of fit test yielded a P-value of 0.86,
suggesting that the model fitted the data in which it was
developed well. The c statistic of the original model was
0.73, meaning that the model discriminates reasonably
between patients who die within 60 days from onset of the
SAH and those who survive this period.
Validation by means of 300 bootstrap samples resulted
in a shrinkage factor of 0.85, which was applied to the
betas of the model. The c statistic of the internally vali-
dated model was 0.70. Details of the final prognostic model
for 60 day case-fatality are described in the appendix.
Discussion
We developed a prognostic model to predict the risk of
60 day case-fatality in individual patients after aSAH.
Predictions were based on characteristics that are regularly
readily available on admission to a neurological or neuro-
surgical unit and which were collected in a large clinical
trial. The full model yielded a c statistic of 0.73.
Previously, several models to estimate the probability of
unfavourable outcome after aSAH have been developed.
Our model was similar to those; we included roughly the
same predictors: age, clinical status, and lumen size [4, 5,
9]. However, our study is of added value because of the
substantial size and the inclusion of both clipped and coiled
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patients. The studies by Hoh et al. [4] (n = 515) and
Mocco et al. [9] (n = 148) contained relatively few
patients. The small numbers of coiled patients (79 and 35,
respectively) and the design of the study did not allow for
taking the effect of treatment in consideration. The study of
Rosengart et al. [5] (n = 3,667) was not able to do that
Table 1 Population characteristics and univariate association with 60 day case fatality
Predictor Alive n = 1,975 Death n = 153
Median IQR Median IQR Beta SE OR CImin CImax
Age [10 years] 5.2 4.3–5.9 5.6 5.0–6.5 0.36 0.08 1.43 1.23 1.66
Lumensize [mm] 5 4–7 6 4–8 0.10 0.02 1.10 1.05 1.15
n % n %
Sex
Female 1,236 63 103 67 1
Male 739 37 50 33 -0.21 0.18 0.81 0.57 1.15
Previous SAH
Yes 129 7 6 4 -0.54 0.43 0.58 0.25 1.35
No 1,846 93 147 96 1
Fisher grade
1 112 6 2 1 1
2 350 18 10 7 0.47 0.78 1.60 0.35 7.41
3 840 43 62 41 1.42 0.73 4.13 1.00 17.13
4 673 34 79 52 1.88 0.72 6.57 1.59 27.13
Lumbar puncture
Xanthochromia or blood 217 11 7 5 -0.95 0.39 0.39 0.18 0.84
No blood 5 0 0 0 -5.19 20.8 0.01 0.00 ?
No puncture 1,753 89 146 95 1
WFNS grade
1 1,270 64 54 35 1
2 495 25 51 33 0.89 0.20 2.42 1.63 3.60
3 120 6 13 8 0.94 0.32 2.55 1.35 4.80
4 55 3 19 12 2.09 0.30 8.12 4.51 14.63
5 13 1 7 5 2.54 0.49 12.66 4.86 33.02
6 (not assessable) 22 1 9 6 2.26 0.42 9.62 4.23 21.89
n of aneurysms detected
1 1,555 79 116 76 1
2 314 16 29 19 0.21 0.22 1.24 0.81 1.89
C3 106 5 8 5 0.10 0.38 1.10 0.52 2.32
Location
ACA 1,008 51 71 46 -0.16 0.19 0.85 0.59 1.23
ICA 638 32 53 35 1
MCA 277 14 23 15 0.00 0.26 1.00 0.60 1.66
PC 52 3 6 4 0.33 0.45 1.39 0.57 3.38
Vasospasm
None 1,575 80 109 71 1
Mild 218 11 24 16 0.46 0.24 1.59 1.00 2.53
Moderate/severe 182 9 20 13 0.77 0.26 2.15 1.30 3.55
Intended treatment
Clip 983 50 83 54 1
Coil 992 50 70 46 -0.18 0.17 0.84 0.60 1.16
IQR, inter quartile range; beta, regression coefficient in the logistic regression model; SE, standard error; OR, odds ratio; CImin, lower limit of the
95% confidence interval; CImax, upper limit of the 95% confidence interval
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either, since patients treated with Guglielmi or other
detachable coils were excluded. All three studies used a
dichotomized ordinal scale as an outcome, for which the
cut off can be (arbitrarily) chosen in different studies. In a
sense, examining case-fatality is also a dichotomization of
an ordinal scale, though less arbitrary. Therefore, we are
convinced that logistic regression is well suited for an
outcome that is by its nature dichotomous, whereas for an
ordinal outcome we would prefer specific modelling
techniques.
Several limitations of this study should be acknowl-
edged. This study used data from one large trial on a
selected population of patients who survived the early stage
up till a treatment decision and who were in equipoise
regarding that decision on treatment with either endovas-
cular coiling or neurosurgical clipping, which may limit
external validity. The model may perform well in this
development sample, but worse when applied to other
groups of patients, for example, a less strictly selected
population. Nonetheless, according to a recently published
paper, the ISAT population proved to be quite similar to
the population admitted with an aSAH to neurosurgical
units in the United Kingdom [10]. Although in ISAT, a
lower proportion of poor grade patients were enrolled.
Validation of a prognostic model in independent patient
series is therefore considered an essential next step [11].
However, since large samples of systematically collected
data on aSAH are sparse, assessment of external validity is
difficult. For now the external validity of our model
remains to be established. This will be a topic of future
research.
Although our model represents knowledge obtained
from 2,128 SAH patients in equipoise regarding treatment,
statistical models can never replace the clinician with
regard to decision making; they can only assist with this
task. A prediction for an individual aSAH patient a par-
ticular situation is always subject to uncertainty. The model
makes certain structural assumptions and statistical inter-
action terms were not included. It is hence possible that
specific patterns of risk factors are inadequately reflected in
the model predictions. Therefore, predictions should be
regarded with care and not directly be applied for treatment
limiting decisions.
Although the performance of the presented model was
satisfactory, it might potentially be improved by including
neuro-imaging biomarkers other than lumen size, location,
Fisher grade on plain CT scan, and vasospasm on angi-
ography. Biomarkers regarding anatomy and morphology
might be considered, as well as aneurysm characteristics
obtained from three and four dimensional angiography [12,
13]. Performance may also be improved by inclusion of
subsequent information obtained after admission, including
temporal course, neuro-imaging at later time points,
eventual rebleeding of the aneurysm, delayed ischemic
deficit, and other parameters such as hydrocephalus. The
objective of the present study, however, was to investigate
prognostic models that predict 60 day case-fatality with
predictors available on admission.
Statistical testing for calibration has a number of
drawbacks. First, the null hypothesis is of good calibration.
Hence, if we test calibration in a small study, we have low
power and will not reject the null hypothesis unless mis-
calibration is very severe. On the other hand, even a model
with very good, though not perfect, calibration will fail the
test in case of a sufficiently large sample. Moreover,
reported goodness-of-fit tests are usually non-significant if
they reflect apparent validation on the data that were also
used to construct the model. Such non-significant results
may contribute to the face validity of a model, but have no
real scientific meaning [7].
In conclusion, we presented a prognostic model for
predicting 60 day case-fatality after aneurysmal SAH. Our
model contained age, lumen size, Fisher grade, and WFNS
grade as predictors. After calibration and internal valida-
tion, our model showed reasonable performance, although
external validity of our model remains to be established.
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4 4.87 2.60–9.14
5 7.00 2.54–19.28
6 5.75 2.41–13.73
Age [10 years] 17 1 4 9 10-5 1.32 1.13–1.55
Lumen size [mm] 12 1 4 9 10-4 1.08 1.03–1.13
Fisher grade 8 3 0.04 Grade 1 = ref.
2 1.43 0.27–7.65
3 2.67 0.53–13.51
4 2.76 0.54–14.14
X2 is the chi squared test statistic for the predictor in the final model;
df = degrees of freedom
95% CI was calculated based on the S.E. of the estimates of the
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Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage
123
Conflicts of interest AJM has a consulting agreement with Micrus
Endovascular, a manufacturer of detachable platinum coils. AJM,
RSCK, and JY have received assistance with travel and meeting
expenses from Boston Scientific Corporation. RR, HFL, ABM, CMF,
MS, EWS, and MCJMS have no conflicts of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
Appendix
Details of the prognostic model
The probability of dying within 60 days is calculated
according to the logistic formula: 1/(1 ? exp-LP). The
linear predictor (LP) takes the form of LP = intercept ?
regression coefficients 9 predictor values.
LP for 60 day case-fatality = -5.812 ? 0.2762 9 age ?
0.3572 9 [Fisher grade II] ? 0.9756 9 [Fisher grade III]
? 1.008 9 [Fisher grade IV] ? 0.6216 9 [WFNS grade 2]
? 0.5261 9 [WFNS grade 3] ? 1.574 9 [WFNS grade 4] ?
1.934 9 [WFNS grade 5] ? 1.738 9 [WFNS grade not
assessable] ? 0.07662 9 lumen size of aneurysm.
Coding of the predictors was as follows: age in decades,
lumen size in millimetres; all other predictors, 1 if true and
0 if false.
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